ReviewFrontiers in oncology2026

Identification of metabolic vulnerabilities and synthetic lethal targets utilizing artificial intelligence-driven precision medicine.

Rashid Mir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.